Summary Biosceptre International Ltd (Biosceptre) is a biotechnology company that develops antibody technologies for applications in the diagnosis and treatment of cancer.The company develops imaging technologies to detect and monitor cancer.
Its diagnostic products are used for the detection of various cancer tissues, and treatment of various cancers in humans and other mammals.Biosceptre offers clinical product development programs such as polyclonal antibody, domain antibodies and topical formulation to treat basal cell carcinoma and other skin cancers.
The company also develops diagnostics and a line of veterinary therapeutic products.It has operations in the UK, Australia, and the US.
Biosceptre is headquartered in Cambridge, the UK.
Biosceptre International Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
175 pages •
By The Business Research Company
• Oct 2021
Major players in the augmented reality in health care market are Microsoft Corporation, Sony Corporation, Siemens Healthineers, Koninklijke Philips N.V., CAE Healthcare, 3D Systems, Augmedix, AccuVein Inc., Osterhout Design Group Inc., Magic Leap Inc., Atheer Inc, VirtaMed, and ARToolworks Inc. The global augmented reality in health...
The global self-service technology market grew at a CAGR of around 7% during 2015-2020. Self-service technology (SST) offers an interface through which users can obtain services without the direct involvement of service firms. It provides direct assistance to users, reduces labor costs and improves business productivity....
The global track and trace solutions market grew at a CAGR of around 15% during 2015-2020. Track and trace (T&T) solutions help organizations in managing their supply chain and mitigating risks associated with counterfeit products. They offer transparency, product ID verification services, facilitate the hassle-free...
The global artificial insemination market reached a value of US$ 2,034 Million in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 8.5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of...
The global ambulance services market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...
The global healthcare CRM market reached a value of US$ 10 Billion in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 13.8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic...
Executive Summary The Global Human Nutrition Market was valued at USD 252.38 Billion in the year 2020. The major factors driving the growth of the global Human Nutrition market are growing demand for safe and nutritious health products and supplements, rising disposable income and increasing concern over health among consumers. Based...
The global PCaaS market was valued at USD 21.48 billion in 2020. It is expected to reach USD 176.20 billion by 2026, registering a CAGR of 35.36% during 2021-2026. The outbreak of COVID-19 led to the market’s decline. Notwithstanding the rise in demand for laptops because of the surge in remote working and learning requirements, global PC...
The global healthcare PPE market generated revenue of approximately $19.16 billion in 2020. Revenues will increase to $21.97 billion in 2021, as the COVID-19 pandemic continues to drive a growth rate of 14.7%. The medical gloves segment, comprising surgical and examination gloves, was the largest product segment, increasing 56.6% in 2020 to...
Executive Summary The Global Transcatheter Tricuspid Valve Intervention (TTVI) market is projected to display noteworthy growth and estimated to reach value of USD 10.17 billion by the year 2030 with Europe region leading the regional market share. Demand for transcatheter valvular therapeutics for tricuspid valve diseases...
Health Expenditure Per Capita
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.